Project Oncology®
En podcast af ReachMD
190 Episoder
-
Preventing Adverse Events in CAR T-Cell Therapy: The Evolution of Safety Protocols
Udgivet: 2.1.2025 -
Treating Second-Line NSCLC: The Efficacy of ADCs Targeting Predictive Biomarkers
Udgivet: 31.12.2024 -
Treating NSCLC with Durvalumab, Chemotherapy, and Novel Agents: Preliminary Results
Udgivet: 23.12.2024 -
Evaluating Valemetostat and Dato-DXd for NSCLC: An Upcoming Trial
Udgivet: 23.12.2024 -
Dato-DxD for NSCLC: A Review of Final Overall Survival Data from TROPION-Lung01
Udgivet: 23.12.2024 -
Analyzing Dato-DXd for Non-Squamous NSCLC with Brain Metastases
Udgivet: 23.12.2024 -
Understanding Heparin Resistance: Underlying Mechanisms and Alternative Treatment Options
Udgivet: 16.12.2024 -
The Future of ITP Care: Exploring New Treatments
Udgivet: 16.12.2024 -
Understanding iMCD Through RNA Sequencing
Udgivet: 16.12.2024 -
NSCLC Care: Predicting Response to Dato-DXd with a TROP2 Biomarker
Udgivet: 13.12.2024 -
Diagnosing Castleman Disease: Key Considerations
Udgivet: 10.12.2024 -
Improving Diagnosis of Castleman Disease: The Key Role of Stromal Cells
Udgivet: 9.12.2024 -
Poster Pearl: Treating ER+/HER2- mBC with Elacestrant and Endocrine Therapy
Udgivet: 27.11.2024 -
EMERALD Expert Views: Managing ER+/HER2-, ESR1m mBC Disease Progression Post ET+CDK4/6i
Udgivet: 26.11.2024 -
The Long-Term Safety of Momelotinib for Myelofibrosis: A Poster from ASH
Udgivet: 29.10.2024 -
Poster Pearl: Elacestrant + Abemaciclib for ER+/HER2- Metastatic Breast Cancer
Udgivet: 29.10.2024 -
Investigating the Impact of Momelotinib on Myelofibrosis Patients: A Poster from ASH
Udgivet: 29.10.2024 -
Enhancing Outcomes in Relapsed/Refractory B-ALL with CAR T-Cell Therapy
Udgivet: 16.10.2024 -
Momelotinib vs. Ruxolitinib: Comparing Efficacy in Myelofibrosis and Anemia Patients
Udgivet: 2.10.2024 -
From MGUS to Multiple Myeloma: Understanding the Progression of Precursor Diseases
Udgivet: 16.9.2024
Showcasing major breakthroughs in cancer care from worldwide clinical trials, Project Oncology® educates and assists the healthcare professionals who dedicate their lives to helping patients fight cancer. Here you’ll find leading oncologists discuss and share essential cancer care strategies for all different types of cancer. And as worldwide clinical trials continue to explore new screening tests and discover novel treatment options, you can rest assured that you’ll always catch the latest in cancer research with Project Oncology®.
